Clinical Trials Logo

Clinical Trial Summary

Researchers are looking for a different way to treat people who have an injury to their muscles, ligaments, or tendons in their legs or feet. This is known as a "soft tissue" injury. Before a treatment is available to all patients, researchers study it in trials to better understand its safety and how well it works. People with soft tissue injuries can have pain, swelling, and bruising. In this trial, the researchers want to learn more about the trial treatment, BAYH006689, in participants with a soft tissue injury to their legs or feet. BAYH006689 is a naproxen gel that is used for the temporary relief of minor aches and pains of muscles and joints. The researchers will learn more about how BAYH006689 works and how safe it is in these participants. The trial will include about 100 male and female participants between the ages of 18 and 60. All the participants will have a soft tissue injury to their legs or feet that was caused by playing sports. The injury will have happened within 3 hours of joining the trial. The researchers will use a computer program to randomly choose what treatment each participant will receive. This will help make sure the treatments are chosen fairly and that comparing the results of the treatments is as accurate as possible. The participants will be randomly chosen to be in 1 of 3 groups: - Group 1: 4 grams (g) of BAYH006689 - Group 2: 4 g of a diclofenac diethylamine gel - Group 3: 4 g of a placebo A placebo looks like a treatment but does not have any medicine in it. Diclofenac diethylamine gel is a treatment already available for doctors to be recommended to people with soft tissue injuries. The participants will receive their treatment once in the evening on Day 1 and then 2 times a day for 4 days. The participants will receive their final dose in the morning of Day 6. The doctors will apply the treatment to the participants' skin where the injury is. The participants must be present at the clinic site 11 times over six days: once on Day 1 and twice daily on Days 2-6. During the trial, the doctors will: - check the participants' overall health and ask if they have any medical problems - do physical examinations to check the participants' injuries - use a device to see how tender and sore the participants' injuries are In this trial, the researchers will study how tender the participants' injuries are after 3 days and at other time points over the 6 day follow-up period. They will also study how many participants have medical problems during the trial.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05026320
Study type Interventional
Source Bayer
Contact Bayer Clinical Trials Contact
Phone (+)1-888-84 22937
Email [email protected]
Status Recruiting
Phase Phase 2
Start date August 8, 2021
Completion date November 29, 2021

See also
  Status Clinical Trial Phase
Completed NCT00537784 - Platelet Concentrate in Achilles Tendon Repair N/A
Completed NCT02145130 - Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects Phase 1
Terminated NCT00567528 - Comparison of the Efficacy of Topical Ibuprofen to Oral Ibuprofen in Adolescent Athletes N/A
Withdrawn NCT01497678 - Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) Coordinating Center N/A
Recruiting NCT01063465 - Measurement of Mechanical Properties of the Healing Achilles Tendon With or Without Early Weightbearing N/A
Active, not recruiting NCT00264511 - Hyperbaric Oxygen in Lower Leg Trauma Phase 2/Phase 3
Completed NCT01292876 - Musculotendinous Tissue Repair Unit and Reinforcement (MTURR) N/A
Completed NCT00796094 - Imaging of Soft Tissues N/A
Completed NCT00931866 - Diclofenac Patch for Treatment of Acute Pain Due to Mild to Moderate Soft Tissue Injuries (TAPED) Phase 3